支持在老年人和残疾人护理中适当使用心理药物
Stephen Macfarlane1,2,3,4,5,6, Julian N Trollor1,2,3,4,5,6, Rebecca Koncz1,2,3,4,5,6
1Dementia Support Australia.
Australian prescriber
|February 25, 2026
概括
新的指导方针涉及心理药物在老年护理和残疾方面的使用. 心理药物在认知障碍或障碍临床护理标准促进以人为中心的方法和药物治疗前的替代方案.
科学领域:
- 临床护理标准 临床护理标准
- 卫生政策 卫生政策
- 心理药理学 心理药理学
背景情况:
- 皇家委员会强调了对心理药物滥用作为认知障碍患者化学克制的担忧.
- 这种滥用在老年护理和残疾部门普遍存在,需要改进指南.
研究的目的:
- 为提供心理药物在认知障碍或障碍临床护理标准 (标准) 的概述.
- 概述标准在老年护理和残疾人服务中的应用.
- 促进支持认知障碍或认知障碍患者的最佳实践.
主要方法:
- 该标准强调以人为中心的护理,优先考虑全面的评估和非药物治疗策略.
- 它要求在考虑使用精神药物之前制定个人行为支持计划.
- 鼓励制定明确的记录,监控,知情同意和减产政策.
主要成果:
- 该标准指导心理药物使用,重点是尽量减少危害,并确保适当的处方.
- 它倡导明确的治疗目标,有效的临床转移和定期的药物审查.
- 重点是减少长期使用和心理药物多药.
结论:
- 该标准为在认知障碍中安全有效地使用心理药物提供了框架.
- 实施旨在提高护理质量,减少对化学限制的依赖.
- 遵守标准对于保护脆弱个体至关重要.
相关概念视频
01:15Drug Dosing: Geriatric Patients
321
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
321
01:28Drug Therapy
322
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
322
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
278
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
761
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
761
01:26Psychosis: Goals of Pharmacotherapy
639
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
639
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
298
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
298